Real-world evidence of the effect of adjunctive semaglutide on weight change, glycemic control, and metabolic dysfunction-associated steatotic liver disease in people with type 1 diabetes

Source
Diabetes technology and therapeutics - ISSN 1520-9156- (2025) p.
Author(s)

Gradual DNA methylation changes reveal transcription factors implicated in metabolic dysfunction-associated steatotic liver disease progression and epigenetic age acceleration

Source
Clinical epigenetics - ISSN 1868-7075-17:1 (2025) p. 1-22
Author(s)

Reply to: "Correspondence on "Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD""

Source
Journal of hepatology - ISSN 0168-8278-83:1 (2025) p. e21-e22
Author(s)

Global research initiative for patient screening on MASH (GRIPonMASH) protocol : rationale and design of a prospective multicentre study

Source
BMJ open - ISSN 2044-6055-15:5 (2025) p. 1-11
Author(s)
    Vivian D. de Jong, Marco Alings, Radan Bruha, Helena Cortez-Pinto, George V. Dedoussis, Michail Doukas, Sven Francque, Celine Fournier-Poizat, Amalia Gastaldelli, Thomas Hankemeier, Adriaan G. Holleboom, Luca Miele, Christophe Moreno, Jean W.M. Muris, Vlad Ratziu, Manuel Romero-Gomez, Joern M. Schattenberg, Lawrence Serfaty, D. Cristina Stefan, Maarten E. Tushuizen, Joanne Verheij, Jose Willemse, Oscar H. Franco, Diederick E. Grobbee, Manuel Castro Cabezas